Fosun Pharma tumbles in HK debut, bodes ill for new deals

Fosun Pharmaceutical’s $512 million equity offering was the biggest to hit Hong Kong in three months and was seen a test case by many for future deals. The disappointing start is a warning for other IPO hopefuls, including an up to $6 billion …

Share